文献速递新生儿儿童感染儿童心血管与肾脏

去甲肾上腺素与多巴胺用于新生儿脓毒性休克一线治疗

Norepinephrine versus Dopamine for Septic Shock in Neonates: A Randomized Controlled Trial.
PubMed 文献 · J Pediatr · 2025-04-17

这项随机对照试验纳入80例液体复苏无效的脓毒性休克新生儿,分别以去甲肾上腺素(NE,n=41)或多巴胺(DA,n=39)作为一线血管活性药物。DA组心动过速更多、脑组织氧饱和度更低、24小时pH更低。

要点

  • NE与DA作为一线血管活性药在30分钟休克逆转比例上无显著差异
  • DA组心动过速发生率更高,脑组织氧饱和度与24小时pH更低
  • 两组追加血管活性药、激素、乳酸、高血糖与死亡率等结局相当

核心结论

  • 在液体复苏无效的脓毒性休克新生儿中,去甲肾上腺素与多巴胺作为一线血管活性药物疗效相当。

研究设计与样本

  • 随机对照试验,纳入80例液体复苏无效的脓毒性休克新生儿,NE组41例、DA组39例,NE起始0.2 μg/kg/min、最大0.3 μg/kg/min,DA起始10 μg/kg/min、最大15 μg/kg/min。

主要发现

  • 休克逆转时间、追加血管活性药与激素需求、乳酸水平、高血糖、死亡率及其他并发症在两组间相当。
  • DA组心动过速发生率更高,脑组织氧饱和度更低,入组24小时pH更低。

关键数值与推荐

  • 主要结局为血管活性支持启动30分钟时休克逆转的新生儿比例。

临床怎么用

  • 新生儿脓毒性休克一线血管活性药可考虑NE或DA,需结合心率、脑氧饱和度及酸碱状态个体化选择。

局限性

  • 样本量较小(80例),主要结局差异未达统计学意义,可能不足以排除临床相关差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the effect of norepinephrine (NE) vs dopamine (DA) as first-line vasoactive agent in neonates with fluid-refractory septic shock. STUDY DESIGN: In this randomized controlled trial, 80 neonates with fluid-refractory septic shock were allocated to receive either NE (n = 41) or DA (n = 39) as the first-line vasoactive drug. NE and DA were initiated at a dose of 0.2 and 10 μg/kg/min and escalated to a maximum dose of 0.3 and 15 μg/kg/min, respectively. The primary outcome was the proportion of neonates with shock reversal at 30 minutes of initiation of vasoactive support. Other outcomes included time to shock reversal, requirement of additional vasoactive drugs and steroids, changes in cerebral tissue oxygen saturation, and acid-base parameters and lactate levels at 6-8 and 24 hours. Incidence of mortality, hyperglycemia, tachycardia, and other morbidities were recorded. RESULTS: Baseline characteristics were comparable between the 2 groups. The proportion of neonates with shock reversal at 30 minutes was 32% (13/41) and 46% (18/39) in NE and DA groups, respectively (relative risk 0.69, 95% CI 0.39-1.20, P = .19). Time to reversal of shock, need for additional vasoactive drugs and steroids, lactate levels, hyperglycemia, mortality, and other morbidities were comparable. However, neonates in the DA group had a higher incidence of tachycardia, lower cerebral tissue oxygen saturation, and lower pH at 24 hours of recruitment. CONCLUSION: In neonates with septic shock, NE and DA had comparable efficacy as a first-line vasoactive agent. CLINICAL TRIAL REGISTRATION: Clinical trial registry of India, registration no: CTRI/2023/02/049357, registered prospectively on: 01/02/2023, https://trialsearch.who.int/.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Mazhari MYA, Priyadarshi M, Singh P, et al. Norepinephrine versus Dopamine for Septic Shock in Neonates: A Randomized Controlled Trial. J Pediatr. 2025. PMID: 40252959. doi:10.1016/j.jpeds.2025.114599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。